Clinical trials
Phase 3 Epilepsies, Partial trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
31 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 4 |
| 2005 | 1 |
| 2006 | 3 |
| 2007 | 2 |
| 2008 | 5 |
| 2009 | 1 |
| 2011 | 1 |
| 2013 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 22 |
| Terminated | 4 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
| Enrolling by invitation | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 4 |
| GlaxoSmithKline | 3 |
| Pfizer | 3 |
| UCB BIOSCIENCES, Inc. | 3 |
| Marinus Pharmaceuticals | 2 |
| Rapport Therapeutics Inc. | 2 |
| SK Life Science, Inc. | 2 |
| Supernus Pharmaceuticals, Inc. | 2 |
| UCB Pharma | 2 |
| Abbott | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Epilepsies, Partial | 31 |
| Epilepsy | 20 |
| Seizures | 18 |
| Epilepsy, Complex Partial | 1 |
| Epilepsy, Generalized | 1 |
Trials
Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.